Serum Parathormone and Urinary and Nephrogenous Cyclic Amp in Idiopathic Hypercalciuria and in Primary Hyperparathyroidism

  • V. Nunziata
  • G. di Giovanni
  • R. Giannattasio
  • M. Riccio
  • A. Verrillo
  • P. Strazzullo
Conference paper


The mechanisms of idiopathic hypercalciuria (IH) in man are controversial. Primary hyperabsorption1 or a renal tubular leak of calcium2 have both been suggested. Reduced3 or increased4 parathyroid gland (PTG)activity has been described5−7. The purpose of this study was to evaluate PTG activity in hypercalciuric (HC) stone formers and to investigate the effect of various calcium intakes. In order to test the diagnostic validity of the adopted procedure, the results were compared with those obtained in a group of patients surgically proven to have primary hyperparathyroidism (HPT) with frank or intermittent hypercalcemia.


Primary Hyperparathyroidism Idiopathic Hypercalciuria Fasting Urine Renal Leak Relate Clinical Research 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    F. Albright, P. Hennemann, P. Benedict, and A. P. Forbes, Proc. Roy. Soc. Med. 46:1077 (1953).PubMedGoogle Scholar
  2. 2.
    P. H. Hennemann, P. H. Benedict, A. P. Forbes, and H. R. Dudley, New Engl. J. Med. 159:802 (1958).CrossRefGoogle Scholar
  3. 3.
    C. Y. C. Pak, M. Ohata, E. C. Lawrence, and W. Snyder, J. Clin. Invest. 54:387 (1974).PubMedCrossRefGoogle Scholar
  4. 4.
    F. L. Coe, J. M. Canterbury, J. J. Firpo, and E. Reiss, J. Clin. Invest. 52:134 (1973).PubMedCrossRefGoogle Scholar
  5. 5.
    P. Bordier, A. Ryckewart, J. Guéris, and H. Rasmussen, Am. J. Med. 63:398 (1977).PubMedCrossRefGoogle Scholar
  6. 6.
    A. E. Broadus, M. Dominguez, and F. C. Bartter, J. Clin. Endocrinol. Metab. 47:751 (1978).PubMedCrossRefGoogle Scholar
  7. 7.
    C. Y. C. Pak and R. A. Galosy, J. Clin. Endocrinol. Metab. 48:260 (1979).PubMedCrossRefGoogle Scholar
  8. 8.
    A. L. Steiner, C. W. Parker, and D. M. Kipnis, J. Biol. Chem. 247:1106 (1972).PubMedGoogle Scholar
  9. 9.
    J. F. Harper and G. Brooker, J. Cyc. Nucleotide Res. 1:207 (1975).Google Scholar
  10. 10.
    C. D. Arnaud, R. J. Goldsmith, P. J. Bordier, G. W. Sizemore, J. A. Larsen, and J. Gilkinson, Am. J. Med. 56:785 (1974).PubMedCrossRefGoogle Scholar
  11. 11.
    F. P. Muldowney, R. Freaney, and J. G. Ryan, Quart. J. Med. 193:87 (1980).Google Scholar
  12. 12.
    F. L. Coe, M. J. Favus, T. Crockett, A. L. Strauss, J. H. Parks, A. Porat, C. L. Gantt, and L. M. Sherwood, Am. J. Med. 72:25 (1982).PubMedCrossRefGoogle Scholar
  13. 13.
    P. Burckhardt and P. Jaeger, J. Clin. Endocrinol. Metab. 53:550 (1981).PubMedCrossRefGoogle Scholar
  14. 14.
    R. A. L. Sutton and V. R. Walker, New Engl. J. Med. 302:709 (1980).PubMedCrossRefGoogle Scholar
  15. 15.
    M. Peacock, Contrib. Nephrol. 33:152 (1982).PubMedGoogle Scholar
  16. 16.
    M. A. Weber, M. Klerekoper, I. R. Thornell, and G. S. Stokes, J.Clin. Endocrinol. Metab. 40:982 (1975).PubMedCrossRefGoogle Scholar
  17. 17.
    A. E. Broadus, R. Lang, and A. S. Kliger, J. Clin. Endocrinol. Metab. 52:1085 (1981).PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1985

Authors and Affiliations

  • V. Nunziata
    • 1
  • G. di Giovanni
    • 1
  • R. Giannattasio
    • 1
  • M. Riccio
    • 1
  • A. Verrillo
    • 1
  • P. Strazzullo
    • 1
  1. 1.Institute of Internal Medicine and Metabolic Diseases Seconda Clinica MedicaNaplesItaly

Personalised recommendations